Table 1 Summary of the clinical characteristics of patients with FG managed from 2012–2019 (n = 23)
Variable | Range | Median (IQR) | Mean (SD) |
|---|---|---|---|
Age (years) | 16.0–85.0 | 53.0 (45.0–69.0) | 54.7 (18.4) |
Maximum Temperature (°C) | 36.5–39.2 | 37.5 (36.9–38.5) | 37.7 (0.8) |
Heart Rate (/sec) | 76.0–160.0 | 94.0 (86.0–112.0) | 99.9 (19.7) |
Respiratory Rate (/sec) | 17.0–32.0 | 22.0 (20.0–28.0) | 23.4 (4.0) |
PCV (%) | 22.0–39.0 | 27.0 (24.0–33.0) | 28.3 (5.1) |
Units of Blood Transfused | 0.0–4.0 | 2.0 (0.0–2.0) | 1.5 (1.3) |
WBC (cells/ml) | 4,510–28,000 | 12,220 (8,900–17,200) | 13,686 (6,157) |
Na + (mmol/L) | 110.0–149.0 | 133.0 (130.0–140.0) | 132.6 (11.0) |
K + (mmol/L) | 2.9–4.9 | 3.9 (3.5–4.2) | 3.9 (0.6) |
HCO3- (mmol/L) | 19.0–32.3 | 22.0 (20.0–25.5) | 23.0 (3.7) |
Creatinine (mg/dl) | 0.6–10.0 | 1.3 (1.1–1.7) | 2.1 (2.1) |
FGSI | 0.0–15.0 | 5.0 (3.0–10.0) | 6.0 (4.2) |
UFGSI | 2.0–17.0 | 7.0 (4.0–14.0) | 8.1 (4.9) |
Number of Debridement Sessions | 1.0–4.0 | 2.0 (2.0–3.0) | 2.4 (1.0) |
Duration of Hospital Admission (days) | 15.0–82.0 | 48.5 (38.3–68.8) | 51.4 (19.4) |